The growing interest in effective weight management has led to considerable investigation into cutting-edge treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist , has demonstrated promising results in clinical trials, implyi